Asset Planning Services (Pennsylvania)’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,000
Closed -$15K 213
2019
Q3
$15K Hold
2,000
0.01% 186
2019
Q2
$15K Hold
2,000
0.01% 180
2019
Q1
$16K Hold
2,000
0.01% 175
2018
Q4
$15K Hold
2,000
0.01% 178
2018
Q3
$14K Hold
2,000
0.01% 183
2018
Q2
$13K Hold
2,000
0.01% 188
2018
Q1
$13K Hold
2,000
0.01% 189
2017
Q4
$15K Hold
2,000
0.01% 185
2017
Q3
$14K Hold
2,000
0.01% 210
2017
Q2
$17K Hold
2,000
0.01% 191
2017
Q1
$16K Buy
+2,000
New +$17.3K 0.01% 198

Other funds holding RDY

Asset Planning Services (Pennsylvania)'s RDY Position: Q4 2019 in Review

Asset Planning Services (Pennsylvania) sold out of Dr. Reddy's Laboratories (RDY) in Q4 2019, closing a stake of 2,000 shares — an estimated $15K sold.

Asset Planning Services (Pennsylvania) first reported a position in RDY in Q1 2017 and held it in 11 quarters. The position peaked at $17K in Q2 2017. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

  • Asset Planning Services (Pennsylvania) reported no remaining Dr. Reddy's Laboratories position as of Q4 2019 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 2,000 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $15K.
  • Asset Planning Services (Pennsylvania) first reported a position in Dr. Reddy's Laboratories in Q1 2017 and held it in 11 quarters.
  • Asset Planning Services (Pennsylvania)'s Dr. Reddy's Laboratories position peaked at $17K in Q2 2017.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q4 2019, filed 12 Feb 2020.